Nearly half of patients (45%) took two or more GLP-1s over the study period due to insurance coverage changes, weight plateaus, or side effects
During the first three quarters of 2025, Mounjaro sales nearly doubled (up 94%) from $8.010 billion to $15.558 billion, including $6.515 billion garnered in Q3 (more than double a year earlier)while Zepbound sales tripled from $3.018 billion to $9.281 billion, including $3.588 billion racked up in the July-September quarter, nearly triple (185%) Q3 2024
For an athlete trying to absorb 80-100 grams of carbohydrate per hour while racing at threshold intensity, slower gastric emptying is a potential disaster
The key is that your body is not rejecting the medicationit is simply acclimating to a new metabolic state
For every 10,000 people taking GLP-1 medications for a year, roughly 25 more would experience DVT compared to those not taking the medication